CTRI/2014/08/004834招募中4 期
BCG immunotherapy in recurrent multiple verrucae vulgaris.
DR AVTAR KISHAN JAISINGHANI0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patient should have multiple warts (more than 2).
- •2.The age of the patient more than 17 years.
- •3.No concurrent systemic or topical treatment of warts
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
2 期
Repeat BCG Vaccinations for the Treatment of Established Type 1 DiabetesDiabetes Mellitus, Type OneDiabetes Mellitus, Type IAutoimmune DiabetesCovid19NCT02081326Massachusetts General Hospital150
进行中（未招募）
2 期
Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 YearsAutoimmune DiabetesType 1 DiabetesDiabetes MellitusDiabetes MellitusType 1 DiabetesNCT05866536Massachusetts General Hospital100
进行中（未招募）
2 期
Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 DiabetesAutoimmune DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 1NCT05180591Massachusetts General Hospital150
尚未招募
不适用
TB vaccination in diabetes populatioCTRI/2022/07/044500Department of Biotechnology
进行中（未招募）
1 期
B cell therapy followed by T cell therapy to achieve immune tolerance in rheumatoid arthritis with ACPA antiboidies (TOLERA): an unblinded clinical trial in one centre with random assignment to treatment groups in adult patients who failed methotrexate therapyActive rheumatoid arthritis with ACPA antibodies failing methotrexateMedDRA version: 23.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2018-003877-91-DEniversitätsklinikum Erlangen20